Response to the comment on: "Dulaglutide treatment results in effective glycaemic control in latent autoimmune diabetes in adults (LADA): A post-hoc analysis of the AWARD-2, -4 and -5 trials"
- PMID: 29781106
- DOI: 10.1111/dom.13366
Response to the comment on: "Dulaglutide treatment results in effective glycaemic control in latent autoimmune diabetes in adults (LADA): A post-hoc analysis of the AWARD-2, -4 and -5 trials"
Comment on
-
Dulaglutide treatment results in effective glycaemic control in latent autoimmune diabetes in adults (LADA): A post-hoc analysis of the AWARD-2, -4 and -5 Trials.Diabetes Obes Metab. 2018 Jun;20(6):1490-1498. doi: 10.1111/dom.13237. Epub 2018 Feb 21. Diabetes Obes Metab. 2018. PMID: 29377522 Clinical Trial.
-
Comment on: "Dulaglutide treatment results in effective glycaemic control in latent autoimmune diabetes in adults (LADA): A post-hoc analysis of the AWARD-2, -4 and -5 trials".Diabetes Obes Metab. 2018 Jun;20(6):1549-1550. doi: 10.1111/dom.13290. Epub 2018 Apr 17. Diabetes Obes Metab. 2018. PMID: 29536610 No abstract available.
Similar articles
-
Comment on: "Dulaglutide treatment results in effective glycaemic control in latent autoimmune diabetes in adults (LADA): A post-hoc analysis of the AWARD-2, -4 and -5 trials".Diabetes Obes Metab. 2018 Jun;20(6):1549-1550. doi: 10.1111/dom.13290. Epub 2018 Apr 17. Diabetes Obes Metab. 2018. PMID: 29536610 No abstract available.
-
Dulaglutide treatment results in effective glycaemic control in latent autoimmune diabetes in adults (LADA): A post-hoc analysis of the AWARD-2, -4 and -5 Trials.Diabetes Obes Metab. 2018 Jun;20(6):1490-1498. doi: 10.1111/dom.13237. Epub 2018 Feb 21. Diabetes Obes Metab. 2018. PMID: 29377522 Clinical Trial.
-
Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programme.Diabet Med. 2018 Oct;35(10):1434-1439. doi: 10.1111/dme.13697. Epub 2018 Jun 22. Diabet Med. 2018. PMID: 29869810
-
Efficacy and safety of dulaglutide in the treatment of type 2 diabetes: a comprehensive review of the dulaglutide clinical data focusing on the AWARD phase 3 clinical trial program.Diabetes Metab Res Rev. 2016 Nov;32(8):776-790. doi: 10.1002/dmrr.2810. Epub 2016 May 15. Diabetes Metab Res Rev. 2016. PMID: 27102969 Review.
-
Dulaglutide for the treatment of type 2 diabetes.Expert Opin Biol Ther. 2017 Apr;17(4):485-496. doi: 10.1080/14712598.2017.1296131. Epub 2017 Feb 28. Expert Opin Biol Ther. 2017. PMID: 28274140 Review.
Cited by
-
GLP-1 receptor agonist-induced diabetic ketoacidosis: A case report.Medicine (Baltimore). 2024 Sep 27;103(39):e39799. doi: 10.1097/MD.0000000000039799. Medicine (Baltimore). 2024. PMID: 39331877 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources